Verification evidence is still being completed.
PDF / print export
Stem Cell Research Center (SCRC)
Vilnius, Lithuania
- Verified lead
- Vladas Algirdas Bumelis
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Founder and Chairman of the Board, Northway group
- 2026 technical specialization
- Stem Cell Research, Regenerative Medicine Cluster, and 3D Bioprinting R&D
- Review cycle
- 24 April 2026
- Full address
- Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Stem Cell Research Center official site describing the Vilnius cluster and operations.
- Editorial note
- Vilnius Stem Cell Research Center under the Northway group with documented 27 million EUR Vilnius City Innovation Industrial Park investment and a 3D bioprinting research axis.
Stem Cell Research, Regenerative Medicine Cluster, and 3D Bioprinting R&D
Lithuanian Stem Cell and Regenerative Medicine Cluster operator, Northway group parent backing, 27 million EUR investment record
Vilnius Stem Cell Research Center under the Northway group with documented 27 million EUR Vilnius City Innovation Industrial Park investment and a 3D bioprinting research axis.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Vilnius Stem Cell Research Center under the Northway group with documented 27 million EUR Vilnius City Innovation Industrial Park investment and a 3D bioprinting research axis.
- Lead
- Vladas Algirdas Bumelis (verified ↗)
- Address
- Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Research center and cluster operations
- Capabilities
- Stem Cell Research · Regenerative Medicine Cluster Management · 3D Bioprinting R&D
- Founded
- 2010
- Headcount
- 1-10
Clinical profileSTATUS: VERIFIED APRIL 2026
Vladas Algirdas Bumelis
Founder and Chairman of the Board, Northway group
Full addressVilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Northtown Vilnius announcement of the Stem Cell Research Center investment and location.
Open sourceResearch center and cluster operations
Vilnius, Lithuania. Stem Cell Research, Regenerative Medicine Cluster, and 3D Bioprinting R&D. Review completed on 24 Apr 2026.
Lithuanian State Medicines Control Agency and Ministry of Health
Lithuanian Stem Cell and Regenerative Medicine Cluster operator, Northway group parent backing, 27 million EUR investment record
Stem Cell Research, Regenerative Medicine Cluster, and 3D Bioprinting R&D
Vilnius Stem Cell Research Center under the Northway group with documented 27 million EUR Vilnius City Innovation Industrial Park investment and a 3D bioprinting research axis.
Editorial note
SCRC is part of the Northway group (founder and chairman Vladas Algirdas Bumelis) and operates the Lithuanian Stem Cell and Regenerative Medicine Cluster, with documented 27 million EUR investment at Vilnius City Innovation Industrial Park.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Stem Cell Research
Regenerative Medicine Cluster Management
3D Bioprinting R&D
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Stem cell research laboratories
3D bioprinting center
Regenerative medicine cluster coordination
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Stem Cell Research Center (SCRC) located?
- Stem Cell Research Center (SCRC) operates from Vilnius City Innovation Industrial Park (Northtown), Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Stem Cell Research Center (SCRC)?
- Stem Cell Research Center (SCRC) is led by Vladas Algirdas Bumelis, Founder and Chairman of the Board, Northway group. Verified 24 Apr 2026.
- What does Stem Cell Research Center (SCRC) do?
- Vilnius Stem Cell Research Center under the Northway group with documented 27 million EUR Vilnius City Innovation Industrial Park investment and a 3D bioprinting research axis. Core capabilities: Stem Cell Research, Regenerative Medicine Cluster Management, 3D Bioprinting R&D.
Editorial context
Related technical briefs
Briefs that name Vilnius as a covered market or city.